After Bristol Myers pulls out of collaboration, Ikena Oncology lays off 35% of staff and trims cancer pipeline
Ikena Oncology is cutting 35% of its workers to help fund two oncology candidates after dumping two other cancer assets it was slated to work …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
